DUBLIN, April 21, 2022--(BUSINESS WIRE)--The "Holter ECG Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Component (Wired Holter Monitors, Wireless Holter Monitors, and Holter Analysis Systems & Software) and End User (Hospitals & Clinics, Home Settings, Ambulatory Surgical Centers, and Other End Users)" report has been added to ResearchAndMarkets.com's offering.
The Holter ECG market is projected to reach US$ 1,017.57 million by 2028 from US$ 587.61 million in 2021; it is expected to grow at a CAGR of 8.2% during 2021-2028. The market growth is attributed to the growing cases of CVDs.
An ECG Holter monitor is a wearable device that helps in tracking the proper functioning of the heart. The device is used to conduct a Holter test, especially on an individual who is susceptible to develop cardiovascular disease. The individual is asked to wear the device for around two to three days to tracked down the heart's activity. The data obtained is then analyzed with the help of analysis software, which helps the doctors suggest an appropriate treatment to the patient.
In the last decade, the world witnessed notable developments in Holter ECG monitors, aiding physicians and patients with new approaches to manage diseases such as atrial arrhythmias, ventricular arrhythmias, and ventricular atrial fibrillation. The growing prevalence of arrhythmia and other cardiovascular diseases (CVDs) is encouraging the introduction of improved diagnostic methods.
Holter ECG monitors are gaining significant traction as these are simpler and quicker tools used for detecting arrhythmias. Holter monitoring is noninvasive, safer and effective for patient monitoring. According to the World Health Organization (WHO), ~30 million people experience a stroke each year. According to the American Heart Association, almost half of all adults in the US have a type of CVD. Furthermore, more than 130 million people, i.e., 45.1%, of the US population are projected to have a type of CVD by 2035.
The European Society of Cardiology reported that patients suffering from atrial fibrillation are at a five-times greater risk of getting a stroke, and 20-30% of total stroke cases in Europe are caused due to atrial fibrillation. As per a study conducted by the European Society of Cardiology in 2016, ~7.6 million people aged 65 and above had atrial fibrillation in the EU.
The number is estimated to increase by 89% to reach ~14.4 million by 2060. As per the report 'Beyond The Burden: The Impact of Atrial Fibrillation in the Asia Pacific' by Biosense Webster, published in 2019, more than 16 million people in Asia Pacific suffer from atrial fibrillation, and the number is expected to reach ~72 million by 2050. The report also suggests that the middle-aged and elderly population is at a greater risk of developing this condition.
Most types of CVDs can be prevented through pre-monitoring and pre-diagnosis. Likewise, arrhythmias, i.e., abnormalities in the heart functioning, can be averted with early diagnosis. The demand for arrhythmia monitoring devices is increasing as these devices can help save patients at a high risk of cardiac arrest.
This results in the healthcare industry adopting new and innovative devices to ensure enhanced medical care and investing in better healthcare facilities, in turn, boosting demand for monitoring devices such as Holter ECG monitors. To avoid risks associated with CVDs, Holter ECG are widely used by population who are likely to be exposed to factors that cause CVD.
Holter ECG monitor records the heart's activity (ECG) continuously for 24-48 hours, essential for safe diagnosis and therapy control, which is a major factor fueling its demand.
Rising Prevalence of Cardiovascular Diseases (CVDs)
Significant Rise in Elderly Population
Lack of Skilled Professionals Leading to Inaccurate Holter ECG Analysis
Untapped Potential of Emerging Economies
Rising Number of Product Approvals and Launches
SCHILLER Healthcare India Pvt. Ltd.
EB Neuro S.P.A
For more information about this report visit https://www.researchandmarkets.com/r/ub52lh.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220421005892/en/
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Shares of Guardant Health (NASDAQ: GH) were trading 23.4% lower as of 11:51 a.m. ET on Friday. The steep decline came after the company announced its first-quarter results following the market close on Thursday. This result was in line with Wall Street estimates.
The markets went into bloodbath mode on Thursday as all the main indexes tumbled by at least 3%, with the NASDAQ’s 5% drop the most acute. That represented the tech-heavy index’s biggest one-day dive since June 2020. The force of the plunge confirms what we all know by now - the market headwinds are piling up, one upon the other. At its base, the issue is simple: there are too many problems, coming in too fast, and both the impersonal markets and the individual investors are finding it difficult
Just when it looked like time to throw in the towel, the market pulled through and delivered a win. After April turned out to be the worst month since March 2020, May kicked off in a more upbeat fashion, with investors hoping the bottom might be in sight. Whether that is the case or not, remains to be determined, although the one good thing about a bear market is that investors have plenty of opportunities to pick up promising equities at enticing prices. But how to get hold of the next winner?
The move by the FDA comes after the company voluntarily paused enrollment in multiple clinical trials over concerns about potential kidney dysfunction in patients.
For the quarter, Global Blood Therapeutics' sales hit nearly $55.2 million, representing quite an encouraging improvement over the year-ago quarter's $39 million. Although the revenue figure didn't quite reach the $56.1 million analysts were collectively estimating, Global Blood Therapeutics beat on the bottom line. Global Blood Therapeutics also launched the drug for patients aged 4 to 11.
By John Vandermosten, CFA NASDAQ:ECOR READ THE FULL ECOR RESEARCH REPORT On May 5, 2022, electroCore Inc. (NASDAQ:ECOR) posted first quarter 2022 financial and operational results in a press release and Form 10-Q filed with the SEC. A conference call with investors and analysts was held immediately following the release. First quarter revenues of $1.9 million met upwardly revised company guidance
At a gala Thursday night for an anti-abortion group, former Vice President Mike Pence took aim at sitting Vice President Kamala Harris over remarks she delivered at a pro-choice group’s annual gala two nights earlier.
My first thought after attending a four-hour symposium on the health benefits of tea was I need a tall cool glass of iced tea. And I ought to be drinking 1-2 glasses a day.
A deed recently filed in Miami-Dade County records has revealed how much money Nicklaus Children’s Health System obtained for selling the shuttered Miami Medical Center campus. The Miami-based nonprofit announced on April 26 that it sold Miami Medical Center to Dallas-based Steward Health Care, but didn’t disclose the price.
A new study conducted by researchers at Harvard Medical School among others has found that the omicron variant of the coronavirus that causes COVID-19 is just as severe as earlier variants, and not more transmissible but no less severe as previously thought.
But Marco Rubio has proposed a bill that would bar employers from tax breaks for covering such costs
Contrary to popular belief, most Americans don’t live in a place that mirrors their political views — not yet, anyway.
The Drug Enforcement Administration said kids are using emojis for dealing drugs.
The company plans to let go of its CEO and scrap commercial plans for its controversial Alzheimer’s disease drug.
It’s only been about six months since the Omicron variant emerged and changed the landscape of the pandemic, sending case-counts soaring and causing breakthrough infections even among those who were fully vaccinated and boosted. Now, another Omicron descendent known as BA.2.12.1 is accounting for a growing share of U.S. cases—about 36% of samples sequenced during the week ending April 30, according to the U.S. Centers for Disease Control and Prevention (CDC). Two other Omicron spinoffs, known as BA.4 and BA.5, are also currently spreading in South Africa, where they were first identified, and have been detected in other countries around the world.
Veronica thought she did everything right by sticking to all of the COVID-19 lockdown rules in the Chinese city of Shanghai. After the entire city was shut down on April 1, her family of four scrupulously followed government orders to stay at home, stepping out the front door only for mandatory PCR testing. When curbs were relaxed slightly in mid-April, letting residents walk about within their compounds, Veronica and her neighbours all wore masks.
The Covid-19 pandemic killed 13.3 to 16.6 million people in 2020 and 2021, says the World Health Organization - up to triple the number of deaths attributed directly to the disease. The WHO's long-awaited estimate of the total number of deaths caused by the pandemic -- including lives lost to its knock-on effects -- finally puts a number on the broader impact of the crisis.
With a new, fully robotic approach, thoracic surgeons at St. Joseph's Healthcare Hamilton have changed the way that esophageal cancer surgeries are performed. It's the most significant advancement in surgery for esophageal cancer in Canada in more than two decades.
When focusing on weight loss, there are so many diets and habits to help you reach your goals. However, with all the types of diets and foods, how do you know what's the right option for you? You're then trying all these different methods because you hear about celebrity weight loss, or a new trend or popular diet. It seems like finding a way to lose weight is overwhelming.Well now there's one diet you can eliminate from your options. According to a study done by the New England Journal of Medic
Free Crocs giveaway for health care workers returns for National Nurses Week. Crocs has partnered with FIGS to give free scrubs. Enter by May 12.